Skip to search formSkip to main contentSkip to account menu

P-1496

Known as: P 1496, P1496 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
UNC13A influences survival in an Italian population-based series A. Calvo1, G. Restagno2, M. Brunetti2, I. Ossola2, E. Majounie3… 
1983
1983
Previous studies discovered a second class of estrogen-binding proteins distinct from estrogen receptor which exhibited higher… 
1983
1983
Abstract : Exposure to pharmacological dosages of estrogens, including 17 beta- estradiol and DES, selectively affects immune… 
Highly Cited
1982
Highly Cited
1982
We have used a sensitive and quantitative assay to investigate the hormonal regulation of plasminogen activator (PA) activity in… 
1980
1980
The interference of two weak estrogens (P-1496 and P-1560) on the binding of estradiol with uterine estrogen receptors is… 
1977
1977
Abstract. Treatment of postmenopausal women with a non‐steroidal oestrogen (P1496) in a dose of 50 mg a day for 21 days before… 
1975
1975
A double-blind clinical trial has been carried out with a new non-steroidal oestrogenic substance (P1496). Taken cyclically over… 
Highly Cited
1973
Highly Cited
1973
The results are reported of a preliminary trial of P1496, a new non-steroidal oestrogen analogue, compared with a conjugated…